These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
429 related items for PubMed ID: 15878496
1. Benefit from anti-inflammatory treatment during clinical remission of atopic asthma. van den Toorn LM, Prins JB, de Jongste JC, Leman K, Mulder PG, Hoogsteden HC, Overbeek SE. Respir Med; 2005 Jun; 99(6):779-87. PubMed ID: 15878496 [Abstract] [Full Text] [Related]
2. Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma. Fardon TC, Lee DK, Hodge MR, Lipworth BJ. Ann Allergy Asthma Immunol; 2005 Sep; 95(3):259-65. PubMed ID: 16200817 [Abstract] [Full Text] [Related]
3. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study. Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S. Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991 [Abstract] [Full Text] [Related]
4. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma? Koenig SM, Murray JJ, Wolfe J, Andersen L, Yancey S, Prillaman B, Stauffer J, Dorinsky P. Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683 [Abstract] [Full Text] [Related]
5. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma. Dahl R, Chuchalin A, Gor D, Yoxall S, Sharma R. Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212 [Abstract] [Full Text] [Related]
6. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate. Rojas RA, Paluga I, Goldfrad CH, Duggan MT, Barnes N. J Asthma; 2007 Jul; 44(6):437-41. PubMed ID: 17654129 [Abstract] [Full Text] [Related]
7. Comparison between the effects of generic and original salmeterol/fluticasone combination (SFC) treatment on airway inflammation in stable asthmatic patients. Maneechotesuwan K, Assawabhumi J, Rattanasaengloet K, Suthamsmai T, Pipopsuthipaiboon S, Udompunturak S. J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S91-100. PubMed ID: 24772585 [Abstract] [Full Text] [Related]
8. Effect of fluticasone on markers of inflammation and quality of life in steroid-naive patients with mild asthma. Ehrs PO, Sundblad BM, Larsson K. Clin Respir J; 2010 Jan; 4(1):51-8. PubMed ID: 20298418 [Abstract] [Full Text] [Related]
9. Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma. Koopmans JG, Lutter R, Jansen HM, van der Zee JS. Thorax; 2006 Apr; 61(4):306-12. PubMed ID: 16449264 [Abstract] [Full Text] [Related]
10. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study. Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM. Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690 [Abstract] [Full Text] [Related]
11. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Olivieri D, Chetta A, Del Donno M, Bertorelli G, Casalini A, Pesci A, Testi R, Foresi A. Am J Respir Crit Care Med; 1997 Jun; 155(6):1864-71. PubMed ID: 9196087 [Abstract] [Full Text] [Related]
12. Effects of salmeterol and fluticasone propionate combination versus fluticasone propionate on airway function and eosinophilic inflammation in mild asthma. Hoshino M, Handa H, Miyazawa T. Allergol Int; 2009 Sep; 58(3):357-63. PubMed ID: 19454840 [Abstract] [Full Text] [Related]
13. Role of add-on zileuton on total exhaled, large airway, and small airway/alveolar nitric oxide in moderate-severe persistent adult asthmatics on fluticasone 250 microg/Salmeterol 50 microg. Gelb AF, Taylor CF, Simmons M, Shinar C. Pulm Pharmacol Ther; 2009 Dec; 22(6):516-21. PubMed ID: 19467341 [Abstract] [Full Text] [Related]
14. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate. Lundbäck B, Rönmark E, Lindberg A, Jonsson AC, Larsson LG, Pétavy F, James M. Respir Med; 2006 Jan; 100(1):2-10. PubMed ID: 16243498 [Abstract] [Full Text] [Related]
15. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. Fardon T, Haggart K, Lee DK, Lipworth BJ. Respir Med; 2007 Jun; 101(6):1218-28. PubMed ID: 17178217 [Abstract] [Full Text] [Related]
16. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Ward C, Pais M, Bish R, Reid D, Feltis B, Johns D, Walters EH. Thorax; 2002 Apr; 57(4):309-16. PubMed ID: 11923548 [Abstract] [Full Text] [Related]
17. Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils. Koopmans JG, Lutter R, Jansen HM, van der Zee JS. J Allergy Clin Immunol; 2005 Nov; 116(5):1007-13. PubMed ID: 16275368 [Abstract] [Full Text] [Related]
18. Effect of montelukast compared with inhaled fluticasone on airway inflammation. Overbeek SE, O'Sullivan S, Leman K, Mulder PG, Hoogsteden HC, Prins JB. Clin Exp Allergy; 2004 Sep; 34(9):1388-94. PubMed ID: 15347371 [Abstract] [Full Text] [Related]
19. Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone. Chetta A, Zanini A, Foresi A, Del Donno M, Castagnaro A, D'Ippolito R, Baraldo S, Testi R, Saetta M, Olivieri D. Am J Respir Crit Care Med; 2003 Mar 01; 167(5):751-7. PubMed ID: 12468439 [Abstract] [Full Text] [Related]
20. The 24 h duration of bronchodilator action of the salmeterol/fluticasone combination inhaler. Masoli M, Weatherall M, Ayling J, Williams M, Beasley R. Respir Med; 2005 May 01; 99(5):545-52. PubMed ID: 15823450 [Abstract] [Full Text] [Related] Page: [Next] [New Search]